← All organizations

Shanghai HEP Pharmaceatical Co., Ltd.

For profitWebsite ↗

Also known as: Shanghai HEP Pharmaceatical Co., Ltd. | Shanghai HEP Pharmaceutical Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 30, 2026

Timeline

2000s

Jun 1, 2005
Shanghai HEP Pharmaceatical Co., Ltd.— Founded

Drugs by trial phase (4 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

hepalatide

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT07309380Lead sponsorPhase 3Apr 30, 2026
NCT06505928Lead sponsorPhase 2Sep 1, 2024
NCT05827146Lead sponsorPhase 2Oct 15, 2023
NCT05244057Lead sponsorPhase 2Aug 23, 2022
NCT05133856Lead sponsorPhase 2Dec 31, 2021
NCT04662164Lead sponsorPhase 1/Phase 2Dec 31, 2020
NCT04426968Lead sponsorPhase 2Aug 31, 2020
NCT03023787Lead sponsorPhase 1Aug 1, 2016
NCT02612506Lead sponsorPhase 1Oct 1, 2015

Details

Founded: Shanghai, CN Jun 1, 2005
Last known activity: Apr 30, 2026